DRTS — Alpha Tau Medical Ltd.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1871321 ·
Last close
$14.70
Market Cap
$1.36B
52W High
$15.02
52W Low
$8.75
ADV30
564,075
Next earnings
2026-08-10
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 -13,313,000 -22,939,000 108,773,000 4,636,000 39,421,000
Dec 2025 0 -12,602,000 -12,136,000 105,652,000 12,202,000 28,553,000
Sep 2025 0 -10,730,000 -11,686,000 104,694,000 3,329,000 27,110,000
Jun 2025 0 -9,648,000 -10,114,000 110,954,000 11,703,000 24,331,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-213,075,000
Inventory
Receivables
$1,121,000
ST Investments
$71,783,000
EBIT TTM
$-46,164,000
Pretax Income TTM
$-56,864,000
Interest Exp TTM
Analysts
5

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -42,288,000 -42,627,000 105,652,000 28,553,000 -26,681,000
Dec 2024 0 -36,042,000 -31,750,000 86,204,000 23,538,000 -19,783,000
Dec 2023 0 -35,680,000 -29,157,000 107,388,000 22,913,000 -17,958,000
Dec 2022 0 -32,136,000 -33,762,000 120,149,000 14,492,000 -23,879,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.53

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $12.50 · spot: $14.70 · call volume: 561 · put volume: 18
Expected Move to 2027-01-15: ±$5.47 (37.24%) — implied range $9.22$20.17 · ATM straddle on $15.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
AORT ARTIVION, INC. $1.31B $26.89
CDRE Cadre Holdings, Inc. $1.42B $33.08
ATEC Alphatec Holdings, Inc. $1.42B $9.24
IART INTEGRA LIFESCIENCES HOLDINGS CORP $1.30B $16.69
ENOV Enovis CORP $1.45B $25.21

News headlines (Yahoo Finance, 1h cache)

New Strong Sell Stocks for July 2nd
2026-07-02 07:49 · Yahoo
Alpha Tau Medical’s (DRTS) First International Brain Cancer Use Tests The Breadth Of Its Alpha DaRT Platform
2026-06-27 19:06 · Yahoo
DRTS Stock Shot Up A Whopping 22% Today – Why A $196.5M Prostate Cancer Deal Got Investors Buzzing
2026-06-03 14:52 · Yahoo
Alpha Tau Medical Sets Up Catalyst-Rich 2026 as Key Cancer Trial Data Nears
2026-05-29 13:03 · Yahoo
Alpha Tau to Participate in May Investor Conferences
2026-05-18 12:30 · Yahoo
Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study
2026-05-11 14:07 · Yahoo
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Obs
2026-05-11 11:00 · Yahoo
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
2026-06-11 12:30 · Yahoo
Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT® Therapy to U.S. Urological Cancer Patients
2026-06-03 12:30 · Yahoo
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
2026-08-17 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.